ADVERTISEMENT

APhA Policy Manual


  1. APhA supports legal, regulatory, and policy changes to further facilitate clinical research related to the clinical efficacy and safety associated with the use of cannabis and its various components.
  2. APhA encourages health care provider education related to the clinical efficacy, safety, and management of patients using cannabis and its various components.
  3. APhA advocates that the pharmacist collect and document information in the pharmacy patient profile about patient use of cannabis and its various components and provide appropriate patient counseling.
  4. APhA supports pharmacist participation in independently prescribing cannabis and its various components when scientific data support the legitimate medical use of the products and delivery mechanisms, and federal, state, or territory laws or regulations permit pharmacists to independently prescribe them.
  5. APhA opposes pharmacist involvement in independently prescribing cannabis and its various components for recreational use.
Advertisement
Advertisement